HeartSciences Inc.
General ticker "HSCS" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $8.8M (TTM average)
HeartSciences Inc. follows the US Stock Market performance with the rate: 14.2%.
Estimated limits based on current volatility of 6.6%: low 2.64$, high 3.01$
Factors to consider:
- Total employees count: 15 (+25.0%) as of 2024
- Top business risk factors: Limited operating history, Nasdaq delisting risk, Regulatory and compliance, Physician acceptance issues, Payer reimbursement
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-04-30 to 2028-04-29
- 2026-04-30 to 2027-04-30 estimated range: [1.62$, 4.26$]
- 2027-04-30 to 2028-04-29 estimated range: [1.21$, 3.32$]
Financial Metrics affecting the HSCS estimates:
- Negative: with PPE of -0.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: -1.37 < Return on assets ratio (scaled to [-100,100]) of -0.17
- Negative: negative Operating cash flow
- Positive: Industry inventory ratio change (median), % of -0.48 <= -0.26
- Positive: -66.29 < Industry operating profit margin (median), % of -28.35
- Positive: Inventory ratio change, % of 0.66 <= 1.39
- Positive: -1.03 < Investing cash flow per share per price, % of -0.84
Short-term HSCS quotes
Long-term HSCS plot with estimates
Financial data
| YTD | 2024-04-30 | 2025-04-30 | 2026-04-30 |
|---|---|---|---|
| Operating Revenue | $0.02MM | $0.00MM | $0.00MM |
| Operating Expenses | $6.32MM | $8.36MM | $8.42MM |
| Operating Income | $-6.31MM | $-8.35MM | $-8.41MM |
| Non-Operating Income | $-0.30MM | $-0.41MM | $-0.73MM |
| Interest Expense | $0.35MM | $0.50MM | $0.75MM |
| R&D Expense | $2.88MM | $4.39MM | $2,839.01MM |
| Income(Loss) | $-6.61MM | $-8.77MM | $-9.14MM |
| Net Income(Loss)* | $-6.61MM | $-8.77MM | $-9.14MM |
| Stockholders Equity | $7.32MM | $0.21MM | $225.53MM |
| Inventory | $0.63MM | $0.65MM | $655.63MM |
| Assets | $9.50MM | $4.22MM | $5,262.14MM |
| Operating Cash Flow | $-6.07MM | $-7.41MM | $-7.43MM |
| Capital expenditure | $0.13MM | $0.03MM | $0.04MM |
| Investing Cash Flow | $-0.13MM | $-0.03MM | $-0.04MM |
| Financing Cash Flow | $10.34MM | $2.73MM | $8.03MM |
| Earnings Per Share** | $-18.74 | $-9.34 | $-3.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.